| Disease | spondylarthropathy |
| Comorbidity | C0035435|rheumatic disease |
| Sentences | 1 |
| PubMedID- 22088934 | Conclusions: paradoxical ibd may occur during anti tnf-alpha therapy for inflammatory rheumatic disease, mostly in patients with spondylarthropathies while receiving etanercept, at a frequency estimated to 0.15% in the french patients with spondylarthropathies exposed to tnf-alpha antagonists. |
Page: 1